Shenzhen New Industries Biomedical Engineering Future Growth
Future criteria checks 5/6
Shenzhen New Industries Biomedical Engineering is forecast to grow earnings and revenue by 22.5% and 22.3% per annum respectively. EPS is expected to grow by 22.5% per annum. Return on equity is forecast to be 24% in 3 years.
Key information
22.5%
Earnings growth rate
22.5%
EPS growth rate
| Medical Equipment earnings growth | 24.0% |
| Revenue growth rate | 22.3% |
| Future return on equity | 24.0% |
| Analyst coverage | Good |
| Last updated | 28 Apr 2024 |
Recent future growth updates
Recent updates
Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today
Apr 09
The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence
Mar 18Estimating The Fair Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)
Mar 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 7,578 | 3,217 | 2,508 | 2,926 | 8 |
| 12/31/2025 | 6,223 | 2,616 | 1,957 | 2,400 | 13 |
| 12/31/2024 | 4,914 | 2,059 | 1,630 | 2,099 | 10 |
| 3/31/2024 | 4,075 | 1,725 | 1,131 | 1,500 | N/A |
| 12/31/2023 | 3,930 | 1,654 | 1,096 | 1,418 | N/A |
| 9/30/2023 | 3,658 | 1,590 | 797 | 1,222 | N/A |
| 6/30/2023 | 3,495 | 1,508 | 611 | 1,051 | N/A |
| 3/31/2023 | 3,180 | 1,375 | 535 | 961 | N/A |
| 1/1/2023 | 3,047 | 1,328 | 543 | 962 | N/A |
| 9/30/2022 | 2,948 | 1,233 | 633 | 990 | N/A |
| 6/30/2022 | 2,737 | 1,115 | 572 | 931 | N/A |
| 3/31/2022 | 2,756 | 1,114 | 464 | 835 | N/A |
| 1/1/2022 | 2,545 | 974 | 430 | 773 | N/A |
| 9/30/2021 | 2,518 | 906 | 420 | 733 | N/A |
| 6/30/2021 | 2,451 | 892 | 516 | 832 | N/A |
| 3/31/2021 | 2,439 | 997 | 809 | 1,069 | N/A |
| 12/31/2020 | 2,195 | 939 | 722 | 977 | N/A |
| 9/30/2020 | 2,065 | 911 | 764 | 1,009 | N/A |
| 6/30/2020 | 1,911 | 910 | 742 | 960 | N/A |
| 3/31/2020 | 1,655 | 745 | 462 | 754 | N/A |
| 12/31/2019 | 1,682 | 773 | 505 | 832 | N/A |
| 12/31/2018 | 1,384 | 694 | 417 | 702 | N/A |
| 12/31/2017 | 1,141 | 538 | N/A | 525 | N/A |
| 12/31/2016 | 923 | 452 | N/A | 487 | N/A |
| 9/30/2016 | 867 | 380 | N/A | 438 | N/A |
| 6/30/2016 | 811 | 307 | N/A | 389 | N/A |
| 3/31/2016 | 771 | 278 | N/A | 348 | N/A |
| 12/31/2015 | 732 | 249 | N/A | 306 | N/A |
| 9/30/2015 | 677 | 264 | N/A | 278 | N/A |
| 6/30/2015 | 623 | 279 | N/A | 250 | N/A |
| 3/31/2015 | 584 | 266 | N/A | 246 | N/A |
| 12/31/2014 | 545 | 253 | N/A | 243 | N/A |
| 9/30/2014 | 506 | 224 | N/A | 213 | N/A |
| 6/30/2014 | 467 | 194 | N/A | 182 | N/A |
| 3/31/2014 | 423 | 168 | N/A | 160 | N/A |
| 12/31/2013 | 378 | 141 | N/A | 138 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300832's forecast earnings growth (22.5% per year) is above the savings rate (2.9%).
Earnings vs Market: 300832's earnings (22.5% per year) are forecast to grow slower than the CN market (24.4% per year).
High Growth Earnings: 300832's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300832's revenue (22.3% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 300832's revenue (22.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300832's Return on Equity is forecast to be high in 3 years time (24%)